10 selected publications:

1. ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease. Maas-Bauer, K., Stell, A. V., Yan, K. L., de Vega, E., Vinnakota, J. M., Unger, S., Núñez, N., Norona, J., Talvard-Balland, N., Koßmann, S., Schwan, C., Miething, C., Martens, U. S., Shoumariyeh, K., Nestor, R. P., Duquesne, S., Hanke, K., Becher, B.*, Boerries, M.*, Zeiser, R.* (2024). Nature communications, 15(1), 446.
2. Velasco Cárdenas, R. M., Brandl, S. M., Meléndez, A. V., Schlaak, A. E., Buschky, A., Peters, T., Beier, F., Serrels, B., Taromi, S., Raute, K., Hauri, S., Harnessing CD3 diversity to optimize CAR T cells. Gstaiger, M., Lassmann, S., Huppa, J. B., Boerries, M., Andrieux, G., Bengsch, B., Schamel, W. W., & Minguet, S. (2023). Nature immunology, 24(12), 2135–2149.
3. MIRACUM-Pipe: An Adaptable Pipeline for Next-Generation Sequencing Analysis, Reporting, and Visualization for Clinical Decision Making. 
   Metzger, P., Hess, M. E., Blaumeiser, A., Pauli, T., Schipperges, V., Mertes, R., Christoph, J., Unberath, P., Reimer, N., Scheible, R., Illert, A. L., Busch, H., Andrieux, G., Boerries, M. (2023). Cancers, 15(13),3456.
4. Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence. Andrieux, G., Das, T., Griffin, M., Straehle, J., Paine, S. M. L., Beck, J., Boerries, M., Heiland, D. H., Smith, S. J., Rahman, R., Chakraborty, S. (2023). Genome medicine, 15(1), 48.
5. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Ravi, V. M., Neidert, N., Will, P., Joseph, K., Maier, J. P., Kückelhaus, J., Vollmer, L., Goeldner, J. M., Behringer, S. P., Scherer, F., Boerries, M., Follo, M., Weiss, T., Delev, D., Kernbach, J., Franco, P., Schallner, N., Dierks, C., Carro, M. S., Hofmann, U. G., … Heiland, D. H. (2022). Nature communications, 13(1), 925.
6. Spatially confined subtumor microenvironments in pancreatic cancer. Grünwald BT, Devisme A, Andrieux G, Vyas F, Aliar K, McCloskey CW, Macklin A, Jang GH, Denroche R, Romero JM, Bavi P, Bronsert P, Notta F, O'Kane G, Wilson J, Knox J, Tamblyn L, Udaskin M, Radulovich N, Fischer SE, Boerries M*, Gallinger S*, Kislinger T*, Khokha R*. (2021). Cell. Oct 28;184(22):5577-5592.e18, 2021.
7. PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. Cell communication and signaling, Corrales, E., Levit-Zerdoun, E., Metzger, P., Mertes, R., Lehmann, A., Münch, J., Lemke, S., Kowar, S., Boerries, M. (2022).: CCS, 20(1), 187.
8. Harnessing the tissue and plasma lncRNA-peptidome to discover peptide-based cancer biomarkers. Chakraborty, S., Andrieux, G., Hasan, A. M. M., Ahmed, M., Hosen, M. I., Rahman, T., Hossain, M. A., Boerries, M. (2019). Scientific reports, 9(1), 12322.
9. Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Hoefflin, R., Lazarou, A., Hess, M. E., Reiser, M., Wehrle, J., Metzger, P., Frey, A. V., Becker, H., Aumann, K., Berner, K., Boeker, M., Buettner, N., Dierks, C., Duque-Afonso, J., Eisenblaetter, M., Erbes, T., Fritsch, R., Ge, I. X., … Boerries, M.*, Illert, A.L.*, von Bubnoff, N.* (2021). Cancers, 13(5), 1151.
10. Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles. Klett, H., Balavarca, Y., Toth, R., Gigic, B., Habermann, N., Scherer, D., Schrotz-King, P., Ulrich, A., Schirmacher, P., Herpel, E., Brenner, H., Ulrich, C. M., Michels, K. B., Busch, H.*, Boerries, M.* (2018). Epigenetics, 13(4), 386–397.

*equal contribution